Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.

Saved in:
Bibliographic Details
Title: Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Authors: Amaria RN; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Reddy SM; Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Tawbi HA; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Davies MA; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Ross MI; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Glitza IC; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Cormier JN; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Lewis C; Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA., Hwu WJ; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Hanna E; Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA., Diab A; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Wong MK; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Royal R; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Gross N; Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA., Weber R; Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA., Lai SY; Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA., Ehlers R; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Blando J; Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA., Milton DR; Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA., Woodman S; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Kageyama R; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Hwu P; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Patel SP; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Lucci A; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Hessel A; Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA., Lee JE; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Gershenwald J; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Simpson L; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Burton EM; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Posada L; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Haydu L; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Wang L; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA., Zhang S; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA., Lazar AJ; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA., Hudgens CW; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA., Gopalakrishnan V; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Reuben A; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Andrews MC; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Spencer CN; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA., Prieto V; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA., Sharma P; Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA.; Department of Genitourinary Cancers, MD Anderson Cancer Center, Houston, TX, USA., Allison J; Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA., Tetzlaff MT; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational and Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA., Wargo JA; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.
Source: Nature medicine [Nat Med] 2018 Dec; Vol. 24 (12), pp. 1941.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-018-0251-z